Discover the 6 most common causes of mouth rashes in children beyond food allergies, from acidic foods to infections, and ...

Finally, there is excimer laser therapy, a targeted phototherapy treatment for the skin that can aid in treating ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

While winter is often blamed for eczema flare-ups, summer in Tampa Bay brings its own set of skin challenges—especially for residents who live for sunshine, pool days, and ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

Johnson & Johnson has reached an agreement to acquire a bispecific antibody for atopic dermatitis (AD ... also known as eczema. J&J said NM26 has the potential to offer “distinctive benefits ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adults and adolescents aged 12 years and older with ...

On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...